Healthcare provider profile · identity verified

Sweny Gulati, M.D.

Internal Medicine · THE VILLAGES, FL · NPI 1689011736

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	729	224
Losartan Potassium	Losartan Potassium	451	142
Levothyroxine Sodium	Levothyroxine Sodium	419	125
Rosuvastatin Calcium	Rosuvastatin Calcium	398	126
Amlodipine Besylate	Amlodipine Besylate	393	122
Hydrochlorothiazide	Hydrochlorothiazide	320	99
Lisinopril	Lisinopril	295	94
Famotidine	Famotidine	194	58
Trazodone Hcl	Trazodone Hcl	190	55
Omeprazole	Omeprazole	175	58
Metoprolol Succinate	Metoprolol Succinate	154	48
Metformin Hcl	Metformin Hcl	118	37
Escitalopram Oxalate	Escitalopram Oxalate	113	30
Sertraline Hcl	Sertraline Hcl	113	40
Ezetimibe	Ezetimibe	111	37
Pravastatin Sodium	Pravastatin Sodium	106	37
Pantoprazole Sodium	Pantoprazole Sodium	97	41
Gabapentin	Gabapentin	85	31
Eliquis	Apixaban	84	27
Vitamin D2	Ergocalciferol (Vitamin D2)	83	31
Duloxetine Hcl	Duloxetine Hcl	77	21
Alprazolam	Alprazolam	74	37
Fluticasone Propionate	Fluticasone Propionate	71	29
Zolpidem Tartrate	Zolpidem Tartrate	70	19
Fluoxetine Hcl	Fluoxetine Hcl	69	17
Metoprolol Tartrate	Metoprolol Tartrate	67	22
Ozempic	Semaglutide	64	15
Metformin Hcl Er	Metformin Hcl	63	21
Allopurinol	Allopurinol	56	17
Citalopram Hbr	Citalopram Hydrobromide	55	16
Atenolol	Atenolol	54	17
Tamsulosin Hcl	Tamsulosin Hcl	53	21
Alendronate Sodium	Alendronate Sodium	50	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	14
Albuterol Sulfate Hfa	Albuterol Sulfate	45	30
Olmesartan Medoxomil	Olmesartan Medoxomil	44	11
Donepezil Hcl	Donepezil Hcl	43	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	42	11
Simvastatin	Simvastatin	42	13
Bupropion Xl	Bupropion Hcl	40	13
Estradiol	Estradiol	37	19
Buspirone Hcl	Buspirone Hcl	36	11
Sildenafil Citrate	Sildenafil Citrate	34	12
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Furosemide	Furosemide	32	13
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	30	30
Clonazepam	Clonazepam	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Temazepam	Temazepam	27	suppressed
Carvedilol	Carvedilol	26	suppressed
Meloxicam	Meloxicam	26	15
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Glimepiride	Glimepiride	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Ramipril	Ramipril	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	15
Tizanidine Hcl	Tizanidine Hcl	22	13
Montelukast Sodium	Montelukast Sodium	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Prolia	Denosumab	19	13
Lamotrigine	Lamotrigine	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Finasteride	Finasteride	17	suppressed
Valsartan	Valsartan	17	suppressed
Folic Acid	Folic Acid	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Glipizide	Glipizide	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error